How much did ENA Respiratory raise?

ENA Respiratory raised $3M at Debt, announced 3 September 2026.

Who founded ENA Respiratory?

Christophe Demaison is CEO of ENA Respiratory.

What does ENA Respiratory do?

ENA Respiratory operates in HealthTech and is based in Australia.

FundedStartupsDaily / HealthTech / ENA Respiratory

ENA Respiratory raises $3M

ENA Respiratory announced a Debt round of $3M on 3 September 2026. The company operates in HealthTech and is based in Australia. It was founded by Christophe Demaison, CEO.

Raised

$3M

Stage

Debt

Industry

HealthTech

Country

Australia

Founder

Christophe Demaison

CEO, ENA Respiratory

LinkedIn profile enarespiratory.com

Outreach angles

-Demaison leads ENA Respiratory's development of INNA-051, a once-weekly nasal spray designed to strengthen the body's first line of defence against respiratory viruses.
-He previously took the company through a 34 million dollar Series B in 2025 backed by Brandon Capital and Uniseed.
-The new 2.98 million dollar non-dilutive award, one of six grants shared through Australia's Biointelect Venturer program, funds Phase II studies now running in the US ahead of an Australian trial in early 2027.